» Articles » PMID: 34220512

Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression

Overview
Journal Front Pharmacol
Date 2021 Jul 5
PMID 34220512
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The enhancement of tumor targeting and cellular uptake of drugs are significant factors in maximizing anticancer therapy and minimizing the side effects of chemotherapeutic drugs. A key challenge remains to explore stimulus-responsive polymeric nanoparticles to achieve efficient drug delivery. In this study, doxorubicin conjugated polymer (Poly-Dox) with light-responsiveness was synthesized, which can self-assemble to form polymeric micelles (Poly-Dox-M) in water. As an inert structure, the polyethylene glycol (PEG) can shield the adsorption of protein and avoid becoming a protein crown in the blood circulation, improving the tumor targeting of drugs and reducing the cardiotoxicity of doxorubicin (Dox). Besides, after ultraviolet irradiation, the amide bond connecting Dox with PEG can be broken, which induced the responsive detachment of PEG and enhanced cellular uptake of Dox. Notably, the results of immunohistochemistry showed that Poly-Dox-M had no significant damage to normal organs. Meanwhile, they showed efficient tumor-suppressive effects. This nano-delivery system with the light-responsive feature might hold great promises for the targeted therapy for osteosarcoma.

Citing Articles

Cardiomyopathies and a brief insight into DOX-induced cardiomyopathy.

Tanwar S, Dwivedi S, Khan S, Sharma S Egypt Heart J. 2025; 77(1):29.

PMID: 40064787 PMC: 11893974. DOI: 10.1186/s43044-025-00628-0.


Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs-Anthracyclines.

Chen Y, Yang W, Cui X, Zhang H, Li L, Fu J Biology (Basel). 2024; 13(9).

PMID: 39336116 PMC: 11429024. DOI: 10.3390/biology13090689.


Bone targeted nano-drug and nano-delivery.

Wu Y, Sun B, Tang Y, Shen A, Lin Y, Zhao X Bone Res. 2024; 12(1):51.

PMID: 39231955 PMC: 11375042. DOI: 10.1038/s41413-024-00356-2.


Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges.

Andreani T, Cheng R, Elbadri K, Ferro C, Menezes T, Dos Santos M Drug Deliv Transl Res. 2024; 14(10):2845-2916.

PMID: 39003425 PMC: 11385056. DOI: 10.1007/s13346-024-01649-z.


Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review.

Szponar J, Nizinski P, Dudka J, Kasprzak-Drozd K, Oniszczuk A Cells. 2024; 13(13.

PMID: 38995002 PMC: 11240786. DOI: 10.3390/cells13131151.


References
1.
Kawano M, Nishida H, Nakamoto Y, Tsumura H, Tsuchiya H . Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma. Clin Orthop Relat Res. 2010; 468(5):1373-83. PMC: 2853649. DOI: 10.1007/s11999-010-1302-z. View

2.
Zhang X, Wang C, Wu G, Ling B, Liang R, Fang X . Pharmacokinetics of four 5-FU preparations administered rectally to rats and rabbits. World J Gastroenterol. 2016; 3(4):249-50. PMC: 4806249. DOI: 10.3748/wjg.v3.i4.249. View

3.
Hu J, Luo H, Qu Q, Liao X, Huang C, Chen J . Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy. ACS Appl Mater Interfaces. 2020; 12(38):42511-42520. DOI: 10.1021/acsami.0c11636. View

4.
Athanasou N, Bielack S, de Alava E, Dei Tos A, Ferrari S, Gelderblom H . Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21 Suppl 5:v204-13. DOI: 10.1093/annonc/mdq223. View

5.
Hu Q, Katti P, Gu Z . Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale. 2014; 6(21):12273-86. PMC: 4425417. DOI: 10.1039/c4nr04249b. View